Quantcast

Latest UCLA's Jonsson Comprehensive Cancer Center Stories

2008-11-11 06:00:21

The Vanderbilt-Ingram Cancer Center was accredited with the CEO Cancer Gold Standard(TM) certification, recognizing the organization's commitment to the health of their employees and family members by certifying their efforts to meet an exceptionally high standard of cancer prevention, screening and care guidelines. William C. Weldon, chairman and chief executive officer of Johnson & Johnson chairs the CEO Roundtable on Cancer, the nonprofit organization of cancer-fighting CEOs that...

2008-11-04 00:00:05

U.S. researchers found aggressive, personalized treatment increases kidney cancer patient survival compared to the one-size-fits-all traditionally used. Researchers said the landmark University of California, Los Angeles, study of 1,500 patients will allow doctors to better predict which patients will do well and select those who may respond to targeted therapies. The one-size-fits-all approach traditionally used in kidney cancer treatment should be changed based on the results of the...

2008-10-01 18:00:10

By JEREMY COX PART 8BAD NEWS, AGAIN Diagnosed with cancer in her left breast in 1988 and then in her right in 2005, Cathy Holland beat both. When doctors told her that she had esophageal cancer in 2006 and throat cancer a year later, she beat those, too. "I have made it a lot farther than a lot of people," the 56-year- old Jacksonville woman said. "There are a lot of people that get cancer, and you blink your eye and they're gone." Holland is part of a relatively new breed of breast...

2008-10-01 09:00:48

Today, the National Cancer Institute (NCI), the world's pre-eminent cancer research organization which leads the National Cancer Program and the U.S. effort to reduce the burden of cancer, was accredited with the CEO Cancer Gold Standard(TM) certification. NCI joins twenty six other organizations, including two NCI-designated Cancer Centers, that have achieved Gold Standard accreditation, recognizing their efforts to meet an exceptionally high standard of cancer prevention, screening and care...

2008-09-18 09:00:11

By Michelle Dynes Patients need to know where to get care and residents need to learn about prevention. By Michelle Dynes mdynes@wyomingnews.com CASPER - Cancer is the second leading cause of death in Wyoming. But today there are 24,000 residents who are cancer survivors, including 600 patients who are children. People like Kimberly Rogers also work to lessen the impacts of a cancer diagnosis in Wyoming. The program manager for the state Health Department's Comprehensive Cancer...

2008-09-16 12:00:00

PHILADELPHIA, Sept. 16 /PRNewswire/ -- A panel of leading breast cancer experts has identified and prioritized 12 late-stage, or Phase 3, breast cancer research studies, from a total of more than 515 currently underway, with the greatest potential to improve treatment and survival. The 21 experts, all members of the Coalition of Cancer Cooperative Group's Scientific Leadership Council (SLC) in Breast Cancer outlined their consensus -- Research Priorities in Breast Cancer: Recommendations...

2008-09-04 09:00:48

PHILADELPHIA and LONDON, Sept. 4 /PRNewswire/ -- Thomson Reuters, the world's leading source of intelligent information for businesses and professionals, announced today that the National Cancer Institute (NCI) has joined the community of scientists worldwide using BIOMARKERcenter, the first comprehensive resource for biomarker intelligence to provide pharmaceutical, biotechnology, diagnostic, and research organizations with a framework for assessing and tracking a potential biomarker for...

2008-08-15 09:01:04

The finding comes out of a new study released by market intelligence firm Cutting Edge Information. According to Cutting Edge Information's research, total oncology sales will grow by 56% between 2007 and 2012. 2007 sales amounted to approximately $18 billion. The new report, "The Oncology Market Forecast to 2013," is a comprehensive study of more than 135 oncology drugs. The study takes a close look at the market for five major oncology indications, including colorectal, leukemia, lung,...

2008-07-25 09:01:17

Pharmatech, a research management organization, has contracted with five pharmaceutical companies to provide research and site management services for their clinical trials using the just-in-time enrollment strategy. The new trials include the following disease indications: follicular non-Hodgkin's lymphoma, metastatic breast cancer, metastatic sarcoma, chronic myelogenous leukemia, and non-small cell lung cancer. The new oncology clinical trials are targeted to achieve enrollment of over...

2008-06-30 09:03:37

Rising public awareness about breast cancer and the treatments available has greatly improved revenues in the overall breast cancer therapeutics market. To thrive in this highly competitive market, drug developers must offer drugs that improve survival rates and the quality of life. New analysis from Frost & Sullivan (http://www.pharmaceuticals.frost.com), U.S. Breast Cancer Therapeutics Markets, finds that the targeted therapies segment of the market earned revenues of $1.34 billion...


Word of the Day
call-note
  • The call or cry of a bird or other animal to its mate or its young.
'Call-note' is newer than 'bird-call,' which originally referred to 'an instrument for imitating the note of birds' but now also refers to 'the song or cry of a bird.'
Related